Screener
Praxis Precision Medicines, Inc. PRAX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Praxis Precision Medicines, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed November 5, 2025. Open the filing →
- Filed
- Nov 5, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001689548-25-000111
FAQ
- What is Praxis Precision Medicines, Inc.'s EBITDA margin?
- Praxis Precision Medicines, Inc. (PRAX) reported EBITDA margin of -3,925.4% in Q3 2025.
- How has Praxis Precision Medicines, Inc.'s EBITDA margin changed year-over-year?
- Praxis Precision Medicines, Inc.'s EBITDA margin increased by 61.5% year-over-year, from -10,192.7% to -3,925.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Praxis Precision Medicines, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude